Réactifs et instruments pour l'immunologie,
la biologie cellulaire et la biologie moléculaire.
Se connecter
Mot de passe oublié ?
Ouvrir un compte
0
0
Voir le panier
Catalogue
Thématiques
Diagnostic
Services à façon
Services CRO
Ressources techniques
Promotions
Contact
Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
Résultat de votre recherche : 11 produit(s) trouvé(s)
Affinez votre recherche :
RUO
CE / IVD
Class (1)
Biochemicals
Application (1)
WB
8
APPLIQUER LES FILTRES
RéINITIALISER
PARTAGER LA RECHERCHE
COPIé
10
20
50
100
200
500
Référence
Description
Cond.
Prix HT
MBS2086208-0,1mg
OVA conjugated Epidermal Growth Factor (EGF)
0.1mg
MBS2086208-0,2mg
OVA conjugated Epidermal Growth Factor (EGF)
0.2mg
MBS2086208-1mg
OVA conjugated Epidermal Growth Factor (EGF)
1mg
MBS2086208-5mg
OVA conjugated Epidermal Growth Factor (EGF)
5mg
MBS2086208-0,5mg
OVA conjugated Epidermal Growth Factor (EGF)
0.5mg
MBS2086208-0,01mg
OVA conjugated Epidermal Growth Factor (EGF)
0.01mg
MBS2086208-5x5mg
OVA conjugated Epidermal Growth Factor (EGF)
5x5mg
MBS2086208-0,05mg
OVA conjugated Epidermal Growth Factor (EGF)
0.05mg
orb1910500-1g
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
1g
orb1910500-250mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
250mg
orb1910500-100mg
Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.
100mg
‹
›